Literature DB >> 11035871

Genital herpes vaccine shows limited promise.

J Stephenson.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11035871

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously?

Authors:  L Brabin
Journal:  BMJ       Date:  2001-08-18

2.  Towards an effective genital herpes vaccine: past lessons and future prospects.

Authors:  William P Halford
Journal:  Future Virol       Date:  2007-01-01       Impact factor: 1.831

3.  Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases.

Authors:  Sabra L Klein
Journal:  Bioessays       Date:  2012-09-26       Impact factor: 4.345

Review 4.  Vaccines against genital herpes: progress and limitations.

Authors:  Lynda A Morrison
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.

Authors:  William P Halford; Ringo Püschel; Edward Gershburg; Andrew Wilber; Svetlana Gershburg; Brandon Rakowski
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

6.  A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.

Authors:  Ali M Harandi; Kristina Eriksson; Jan Holmgren
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.